Found: 4
Select item for more details and to access through your institution.
Single‐Agent Regorafenib in Metastatic Colorectal Cancer Patients with Any RAS or BRAF Mutation Previously Treated with FOLFOXIRI plus Bevacizumab (PREVIUM Trial).
- Published in:
- Oncologist, 2018, v. 23, n. 11, p. 1271, doi. 10.1634/theoncologist.2018-0316
- By:
- Publication type:
- Article
Correction to: A Phase II Study Evaluating Combined Neoadjuvant Cetuximab and Chemotherapy Followed by Chemoradiotherapy and Concomitant Cetuximab in Locoregional Oesophageal Cancer Patients.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A phase II Study Evaluating Combined Neoadjuvant Cetuximab and Chemotherapy Followed by Chemoradiotherapy and Concomitant Cetuximab in Locoregional Oesophageal Cancer Patients.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A phase 2 study of panitumumab with irinotecan as salvage therapy in chemorefractory KRAS exon 2 wild-type metastatic colorectal cancer patients.
- Published in:
- 2019
- By:
- Publication type:
- journal article